Natural Resin, Gum, Or Balsam As Active Ingredient (e.g., Conifer Resin, Pine Gum, Rosin, Natural Latex, Etc.) Patents (Class 424/195.18)
-
Publication number: 20090143714Abstract: Personal care compositions containing an active selected from the group consisting of Boswellia serratta tree resins and gums, xymenynic acid, glycyrrhizinic acid in extract form, their salts, their derivatives, their precursors, and/or combinations thereof are provided. Methods for regulating the condition of mammalian keratinous tissue by topically applying the personal care compositions are also provided.Type: ApplicationFiled: November 14, 2008Publication date: June 4, 2009Inventors: Cheri Lynn Millikin, Donald Lynn Bissett, Laura Jackson Goodman
-
Publication number: 20090142282Abstract: High-solids solutions of solid rosin esters and lower alcohols can be obtained at rosin ester concentrations above the binary solubility of the rosin ester in the alcohol. Such solutions can be achieved by adding an additional modified rosin or by dissolving a small amount of the alcohol in the rosin ester. These solutions are useful as varnishes for use on humans and animals, particularly when ethanol is the alcohol. The varnish may optionally contain a therapeutic agent.Type: ApplicationFiled: December 1, 2008Publication date: June 4, 2009Inventors: Jonathan Lee Kendall, Donald Wilson Kendall
-
Publication number: 20090081291Abstract: Aspects of the invention include a sustained release dosage form that can be administered to an oral cavity, e.g., the mouth. In certain embodiments, the sustained release dosage form is formulated as a lozenge or gum that may be administered to an oral cavity of a user for the purpose of dissolving over a prolonged period of time and thereby delivering an essential oil component therein. In certain embodiments, the sustained release dosage form includes a beneficial agent and, therefore, not only provides for the prolonged delivery of an essential oil component to an oral cavity, but also provides for the sustained release of a beneficial agent thereto. In certain embodiments, the sustained release dosage form includes a biocompatible, water-insoluble polymer, e.g.Type: ApplicationFiled: September 26, 2007Publication date: March 26, 2009Inventors: Jerry B. Gin, Benjamin F. Ross
-
Publication number: 20090060944Abstract: This invention provides an enhancer of the effect of adrenocorticoid on nephritis without enhancement of the undesirable side-effects of the said adrenocorticoid, comprising the water-soluble gum obtained from the stem and/or branch of Acacia species, e.g., Gum Arabic. The combination of the adrenocorticoid and the said water-soluble gum enhances the effect of the said adrenocorticoid on nephritis without enhancement of the undesirable side-effects of the hormone agent.Type: ApplicationFiled: November 29, 2005Publication date: March 5, 2009Inventors: Michinori Kubo, Yumiko Kubo, Hideaki Matsuda
-
Patent number: 7485309Abstract: This invention is mainly about the making of wounds on the Aquilaria's trunk in order to stimulate the process of Aquilaria resin formation. The wounds in this invention include details of wounds made on the Aquilaria's trunk with the specifications of shape, location, size, beveling, gouging, making holes, and the method of leading the stimulant to Aquilaria through the wounds. The details are shown in this invention. The methods begin with the selection of Aquilaria trees, which have a diameter of about 50 centimeters. Then make a square shaped wound on the trunk with the size and position as specified in the details of the invention. The rims will be gouged as the small channel. Inside the square, make many holes deep into the heartwood. These holes will stimulate Aquilaria to release resin and it is easier to use the stimulant to merge the wounds. In proper time, the resin can be collected and used for further benefits.Type: GrantFiled: March 24, 2004Date of Patent: February 3, 2009Inventor: Pheeraphan Wijitphan
-
Publication number: 20090010958Abstract: A method of modifying perception of a malodor, such as the stench associated with putrefying flesh, by selectively affecting specific olfactory receptors in an individual is disclosed. Disclosed are articles of manufacture and especially innovative compositions effective in implementing the method of the present invention including at least three plant extracts.Type: ApplicationFiled: September 4, 2008Publication date: January 8, 2009Applicant: Patus Ltd.Inventor: Virginia Ruth Pinney
-
Publication number: 20090004220Abstract: Compositions of plant carbohydrates for dietary supplements and nutritional support for promotion and maintenance of good health. Defined nutritionally effective amounts of one to eleven essential saccharides, glyconutrients, are used in various inventive compositions as dietary supplements. The dietary composition herein can include phytonutrients, vitamins, minerals, herbal extracts, and other non-toxic nutrients. The glyconutritional dietary supplement herein provides essential saccharides which are the building blocks of glycoproteins. These compositions, when administered orally or topically, have been found to improve the well being of mammals suffering from a variety of disorders.Type: ApplicationFiled: September 11, 2008Publication date: January 1, 2009Applicant: MANNATECH, INCORPORATEDInventors: Bill H. McAnalley, H. Reginald McDaniel, D. Eric Moore, Eileen P. Vennum, William C. Fioretti
-
Publication number: 20080286299Abstract: The invention provides a biological dressing for treatment of a dermatological disease comprised of one or more resins or other film-forming agents, a topically acceptable volatile solvent, and a pharmacologically active agent. The combined one or more resins are present in a suitable amount such that the composition, when the solvent evaporates, will dry to form a solid coating that sticks to the skin, nail or mucosal membrane to which the composition is applied, and maintain the pharmacologically active agent over a sustained period of time in contact with sites on the skin or mucosal membranes exhibiting symptoms of the disease. Methods are provided for treating symptoms of dermatological diseases with such a pharmacological composition.Type: ApplicationFiled: July 30, 2008Publication date: November 20, 2008Applicant: JALEVA, LLCInventor: Alex Battaglia
-
Publication number: 20080279885Abstract: The present invention refers to a topical formulation containing natural latex or fraction thereof, for topical application, aiming to provide skin regeneration.Type: ApplicationFiled: October 26, 2006Publication date: November 13, 2008Applicant: PELE NOVA BIOTECHNOLOGIA S.A.Inventor: Fatima Mrue
-
Patent number: 7410656Abstract: This invention relates to a compound or group of compounds present in an active principle derived from plants of species Euphorbia peplus, Euphorbia hirta and Euphorbia drummondii, and to pharmaceutical compositions comprising these compounds. Extracts from these plants have been found to show selective cytotoxicity against several different cancer cell lines. The compounds are useful in effective treatment of cancers, particularly malignant melanomas and squamous cell carcinomas (SCCs). In a preferred embodiment of the invention, the compound is selected from the group consisting of jatrophanes, pepluanes, paralianes and ingenanes, and pharmaceutically-acceptable salts or esters thereof, and more particularly jatrophanes of Conformation II.Type: GrantFiled: July 22, 2004Date of Patent: August 12, 2008Assignee: Peplin Research Pty. Ltd.Inventor: James Harrison Aylward
-
Publication number: 20080175889Abstract: A solution of polyether polyurethane resin dissolved in a solvent system containing 2-methyloxolane (2-MeOX) solvent and at least one volatile co-solvent. The solution may also contain a functional amount of solubilized adhesive agent. Upon drying, the resulting protective elastic film has good adhesion to human and other animal skin. The solution penetrates vital tissue to a lesser extent than a comparable solution prepared using tetrahydrofuran solvent.Type: ApplicationFiled: January 23, 2007Publication date: July 24, 2008Inventor: Daniel Perlman
-
Publication number: 20080069862Abstract: A pet supplement includes a joint preserving and joint rebuilding composition comprising chicken collagen type II, glucosamine hydrochloride and chondroitin sulfate, a vitamin composition comprising vitamins C, D and K, a mineral composition comprising calcium, magnesium, zinc, copper, manganese and boron, a herbal anti-oxidant cofactor blend comprising citrus bioflavonoids, red grapes anthocyanins, turmeric rhizome, boswellia resin and fennel seed. Each of these ingredients is intimately mixed into the pet supplement and orally delivered to the pet in the form of a segment, paste or powder having a size and weight or other dosage measuring feature adjusted in accordance with the pet's weight. A synergistic action between these ingredients preserves and rebuilds the pet's joints, and is nutritionally beneficial for the pet.Type: ApplicationFiled: September 15, 2006Publication date: March 20, 2008Inventor: Marni Markell Hurwitz
-
Patent number: 7344728Abstract: An insect repellent composition that includes a blend of either all natural oils or synthetic ingredients, a sunscreen vitamin F, volatile silicones to extend the effective repellent life of the spray and a film forming polymer to resist water wash off. The natural oils and extracts can include citronella and orange and the synthetics can include D-limonene and phtalic acid.Type: GrantFiled: January 30, 2003Date of Patent: March 18, 2008Inventor: Stephen C. Perry
-
Patent number: 7341741Abstract: A polysaccharide selected from xanthan gum and HPMC is used for the treatment or prophylaxis of IBD, especially Crohn's Disease, left-sided ulcerative colitis or pouchitis.Type: GrantFiled: September 25, 1998Date of Patent: March 11, 2008Inventors: Jean-Pierre Sachetto, William Jeffery Sandborn, William John Tremaine
-
Publication number: 20080014261Abstract: The present invention relates to compositions that comprise immediate release and extended release guaifenesin, extended release phenylephrine and immediate and extended release dextromethorphan. The present invention also includes methods for using these compositions for treatment of patients suffering from, for example and without limitation, coughing, sneezing, rhinorrhea, and/or nasal obstruction.Type: ApplicationFiled: July 12, 2006Publication date: January 17, 2008Inventors: John A. Giordano, Kevin M. Brown
-
Patent number: 7288269Abstract: An asafetida extract in the preparation of medicine for abstinence of drugs. A method for abstinence of drugs, which comprises administering a therapeutically effective amount of asafetida extract to subjects. The asafetida extract may be extracted from factice resin of Ferula sinkiangensis K. M. Shen or Ferula fukanensis K.M. Shen, and consists essentially of ?-pinene, ?-terpinene, 2-borneol, terpin-4-ol, D-fenchyl alcohol, pinocarveol, ?-ocimene A, ?-ocimene B, di-sec-butyl disulfide, sec-butyl-trans-1-butenyl disulfide, sec-butyl-cis-propenyl disulfide, sec-butyl-cis-1-butenyl disulfide, sec-butyl-trans-2-butenyl disulfide and thio-sec-butyl-trans-methylethenyl disulfide. The asafetida extract may also be extracted from factice resin of F.Type: GrantFiled: October 13, 2004Date of Patent: October 30, 2007Inventor: Zemin Wang
-
Publication number: 20070148187Abstract: A dietary supplement and herbal formula and treatment methodology for humans and animals, having as its primary ingredient mastic gum extract, for the support, increase and production, function, and/or treatment of the kidneys.Type: ApplicationFiled: November 16, 2006Publication date: June 28, 2007Applicant: Intact Enterprises, Inc.Inventor: Joseph Scivoletto
-
Patent number: 7214379Abstract: Marigold oleoresin having a low viscosity and a high lutein content which can be filled in soft capsules can be obtained according to the method of the present invention, which is characterized by combining a step of subjecting oleoresin to supercritical fluid extraction and a step of dissolving oleoresin in a ketone solvent, cooling the solution and removing the ingredient which precipitated in solution.Type: GrantFiled: September 22, 2003Date of Patent: May 8, 2007Assignee: Riken Vitamin Co., Ltd.Inventors: Shin Sadano, Kazuhiro Fujiwara, Koichi Harada
-
Patent number: 7147860Abstract: Present invention relates to a method and composition for symptomatic relief of vaginitis. Until the treatment of underlying cause takes effect women suffer from unpleasant symptoms of vaginitis restricting daily routine activities. The symptoms of vaginitis may be incapacitating and are a common reason for visiting the gynecologist and can lead to frustration, embarrassment, anger, lost days from work, marital conflict and loss of ability to enjoy a normal personal, professional and social life.Type: GrantFiled: November 27, 2002Date of Patent: December 12, 2006Assignee: Centum Research, LLCInventor: Syed Ritzi
-
Patent number: 7074436Abstract: A method for the production of an extract of Phyllanthus wherein (a) Phyllanthuscomponents are extracted with an ethanol/water mixture of 5–85% m/m to which a heavy-metal chelator is added at a concentration of 0.001–3% m/m; (b) the primary extract obtained in step (a) is contacted and concentrated with (ba) Indian Sterculia gum at a final concentration of 0.5–5.0% mm relative to the sum of the extractive substances or (bb) one or more polymers and impendable and/or soluble substance(s); and (c) the concentrated extract obtained in step (b) is dried. The method according to the invention leads to particularly high yield of pharmaceutically effective plant ingredients and is thus of particular interest for therapeutic applications. In a preferred embodiment of the invention the method according to the invention includes a filtration step of the primary extract. It is further preferred that a lipoid is added during the extraction method. The Phyllanthus Phyllanthus amarus is preferred.Type: GrantFiled: October 5, 2001Date of Patent: July 11, 2006Assignee: Phytrix, Inc.Inventors: Matthias-Heinrich Kreuter, Hildebert K. M. Wagner, Gerolf Tittel
-
Patent number: 7052709Abstract: A substance delivery device includes a combustible paperboard strip and at least one substance toxic to insects and a perfume. The delivery device can take the form of a coil and includes a flexible backing sheet for supporting the combustible paperboard strip. The flexible backing sheet is not capable of combustion. Additionally, the material of the paperboard strip can include a combustion promoter.Type: GrantFiled: June 29, 2000Date of Patent: May 30, 2006Assignee: Raman Boards LimitedInventors: Aroon Raman, Krishna Swamy Raja, Benoy Rema, Gubbi Krishnappa Natesh, Satheesh Kumar, Shankar Manjunatha
-
Patent number: 7018635Abstract: The Methods of the present invention prepare carrageenan products from processed seaweed material using shear stress treatment are disclosed. The carrageenan products comprise at least about 65% by weight of carrageenan and at least about 2% by weight of acid insoluble material. The carrageenan products of the present invention preferably have an onset of hydration below about 40° C. and a color of greater than about 74 *L units. The carrageenan products of the present invention are useful as components in food products, such as, dairy products, meats, and dessert gels as well as non-food products, such as, toothpaste formulations, cosmetics, and paints.Type: GrantFiled: September 13, 2002Date of Patent: March 28, 2006Assignee: FMC CorporationInventors: Albert G. Tsai, Linnea K. Ledwith, Robert Kopesky, Maurice Gerard Lynch, William Ross Blakemore, Peter J. Riley
-
Patent number: 6884421Abstract: The present invention provides a synergistic pharmaceutical composition of butyric acid wheat fiber bran and guar gum and a method of treatment for diabetic nephropathy.Type: GrantFiled: March 27, 2002Date of Patent: April 26, 2005Assignee: Council of Scientific and Industrial ResearchInventors: Paramahans Veerayya Salimath, Kari Sambaiah, Chikunda Dattatreya Nandini
-
Patent number: 6869612Abstract: A purified shilajit composition is provided herein from native shilajit. The composition has an abundance of bioactive components, particularly, at least 0.3%, preferably 0.4-1%, by weight, oxygenated dibenzo-?-pyrones and at least 60%, preferably 65-70%, by weight of fulvic acids of low-to-medium molecular weight ({overscore (M)}n of 700-2000) with an E4/E6 ratio of 8-10 at ?465-665 nm, and whose 2% aqueous solution has a pH of ?7. Personal care, pharmaceutical and nutritional use formulations of the purified shilajit composition also are described.Type: GrantFiled: August 1, 2002Date of Patent: March 22, 2005Assignees: Natreon, Inc., Indian Herbs Research & Supply Company Ltd.Inventor: Shibnath Ghosal
-
Patent number: 6844013Abstract: This invention relates to a compound or group of compounds present in an active principle derived from plants of species Euphorbia peplus, Euphorbia hirta and Euphorbia drummondii, and to pharmaceutical compositions comprising these compounds. Extracts from these plants have been found to show selective cytotoxicity against several different cancer cell lines. The compounds are useful in effective treatment of cancers, particularly malignant melanomas and squamous cell carcinomas (SCCs). In a preferred embodiment of the invention, the compound is selected from the group consisting of jatrophanes, pepluanes, paralianes and ingenanes, and pharmaceutically-acceptable salts or esters thereof, and more particularly jatrophanes of Conformation II.Type: GrantFiled: June 21, 2001Date of Patent: January 18, 2005Assignee: Peplin Research Pty LtdInventor: James Harrison Aylward
-
Publication number: 20040265335Abstract: A therapeutic herbal composition is beneficial for enhancing the immune system and treating such a diverse range of diseases as cancer, AIDS, Epstein Barr syndrome and depression. It is also useful as a general blood tonic. This composition includes the synergistic combination of Boswelia carterii stem resin, Styrax benzoin stem resin, Cinnamomum zeylanicum bark, Curcuma zedoaria root, Syzygium aromaticum fruit, Nardostachys chinensis root, Betula alba bark, Impatiens balsamina bark, Costus spicatus root, Allilum sativum bulb and Cyperus rotundus root.Type: ApplicationFiled: May 18, 2004Publication date: December 30, 2004Applicant: Amazon Biotech Inc.Inventor: Chaim Jeremiah Lieberman
-
Publication number: 20040258712Abstract: A therapeutic herbal composition is beneficial for enhancing the immune system and treating such a diverse range of diseases as cancer, AIDS, SARS, Epstein Barr syndrome, and depression, lymes disease, rheumatic arthritis and the like. It is also useful as a general blood tonic. This composition includes the synergistic combination of Boswelia carterii stem resin, Styrax benzoin stem resin, Cinnamomum zeylanicum bark, Curcuma zedoaria root, Syzygium aromaticum fruit, Nardostachys chinensis root, Betula alba bark, Impatiens balsamina bark, Costus spicatus root, Allilum sativum bulb, Cyperus rotundus root and Hyssopus Officinalis.Type: ApplicationFiled: May 18, 2004Publication date: December 23, 2004Applicant: Amazon Biotech Inc.Inventor: Chaim Jeremiah Lieberman
-
Publication number: 20040241186Abstract: An aromatherapy treatment system that utilizes a sprayable solution of essential oils that are mixed with distilled water. The solution is applied by means of spraying the desired amount around or on the body of the person being treated, to produce healthful effects. The solution is applied to the seven master chakras and/or the aura of the person being treated, and may be used in conjunction with meditation. A special combination of essential oils is related for treatment each of the seven master chakras, and also for the aura.Type: ApplicationFiled: May 28, 2003Publication date: December 2, 2004Inventor: Wentsan G. Huang
-
Publication number: 20040234546Abstract: A therapeutic herbal composition is beneficial for enhancing the immune system and treating SARS, immune disorders, lymes disease, rheumatic arthritis, and cancer. This composition includes the synergistic combination of Boswelia carterii stem resin, Styrax benzoin stem resin, Cinnamomum zeylanicum bark, Curcuma zedoaria root, Syzygium aromaticum fruit, Nardostachys chinensis root, Betula alba bark, Impatiens balsamina bark, Costus spicatus root, Allilum sativum bulb and Cyperus rotundus root.Type: ApplicationFiled: May 18, 2004Publication date: November 25, 2004Applicant: Amazon Biotech Inc.Inventor: Chaim Jeremiah Lieberman
-
Patent number: 6818225Abstract: A process for feeding an animal a diet which alters the function and morphology of the gastrointestinal tract (GIT), a large lymphoid organ in the animal and which improves glucose metabolism, satiety, and nutrient absorption. The process involves feeding a companion animal such as, for example, a dog or cat a diet of a pet food composition containing fermentable fibers which have an organic matter disappearance (OMD) of 15 to 60 percent when fermented by fecal bacteria for a 24 hour period, the fibers being present in amounts from about 1 to 11 weight percent of supplemental total dietary fiber. The animal is maintained on the diet for a sufficient period of time to allow the fermentable fibers to ferment in the GIT of the animal.Type: GrantFiled: August 7, 2002Date of Patent: November 16, 2004Assignee: The Iams CompanyInventors: Gregory D. Sunvold, Michael G. Hayek
-
Patent number: 6787161Abstract: This invention relates to a compound or group of compounds present in an active principle derived from plants of species Euphorbia peplus, Euphorbia hirta and Euphorbia drummondii, and to pharmaceutical compositions comprising these compounds. Extracts from these plants have been found to show selective cytotoxicity against several different cancer cell lines. The compounds are useful in effective treatment of cancers, particularly malignant melanomas and squamous cell carcinomas (SCCs). In a preferred embodiment of the invention, the compound is selected from the group consisting of jatrophanes, pepluanes, paralianes and ingenanes, and pharmaceutically-acceptable salts or esters thereof, and more particularly jatrophanes of Conformation II.Type: GrantFiled: June 21, 2001Date of Patent: September 7, 2004Assignee: Peplin Biotech Pty. Ltd.Inventor: James Harrison Aylward
-
Publication number: 20040146566Abstract: A medication for burns and wounds comprising beeswax in combination with butter and with, in most application, rosin, for providing immediate relief of pain and hastening the scabbing process. For medications with rosin, the formulation comprise 7-14% rosin, 10-50% beeswax and 50-70% butter preferably at a ratio of one part rosin, 2-4 parts beeswax, and 10-12 parts unsalted butter. All ingredients are natural and commercially available. The medication is stable at room temperature and is observed to increase its effectiveness or efficacy with storage.Type: ApplicationFiled: October 29, 2003Publication date: July 29, 2004Inventor: Robert E. Armstrong
-
Publication number: 20040142001Abstract: Methods and compositions are disclosed for prevention or treatment of prostate disorders and ameliorating symptoms thereof, including prostatitis, benign prostate hyperplasia and prostatic carcinoma.Type: ApplicationFiled: January 16, 2003Publication date: July 22, 2004Inventors: Koon Yong Kuok, Hien Ly
-
Publication number: 20040109908Abstract: The present invention refers to a process for modification of the physical and chemical properties of a plant extract of Acacia Mimosa, for tanning and retanning of skins, comprising:Type: ApplicationFiled: May 28, 2003Publication date: June 10, 2004Inventors: Luiz Henrique Lamb, Otavio Decusati
-
Publication number: 20040081664Abstract: A method of producing a processed kava product involves using an extraction solvent, such as liquid CO2, to preferentially extract different kavalactones from the source material at different rates. By controlling the extraction parameters and stopping the extraction before all of the kavalactones have been extracted or allowing the extracted kavalactones to be preferentially precipitated in one or more collection environments, a processed kava product can be produced that has a kavalactone distribution profile that can differ substantially from that of the source material. As a result, roots from a less desirable kava cultivar can be used to produce a processed kava product which has a kavalactone distribution profile that is similar to that of a highly desired cultivar. The kava paste can be further processed to produce a dry flowable powder suitable for use in, e.g., a tableting formula. A rapid dissolve tablet formulation for use in the delivery of kavalactones and other botanicals is also disclosed.Type: ApplicationFiled: October 18, 2002Publication date: April 29, 2004Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall
-
Patent number: 6706263Abstract: Microencapsulated and/or enteric coated compositions containing a mixture of sorbents with specific adsorption affinities for uremic toxins including ammonia, urea, creatinine, phenols, indoles, and middle molecular weight molecules and a bacterial source which metabolizes urea and ammonia are provided. Also provided are methods of using these compositions to alleviate symptoms of uremia in patients.Type: GrantFiled: April 20, 2000Date of Patent: March 16, 2004Assignee: Kibow Biotech Inc.Inventors: Natarajan Ranganathan, Jack Dickstein
-
Publication number: 20040037790Abstract: An oral composition includes an oil extract of mastic and an antiphlogistic. An oral hygiene method includes brushing teeth with a dentifrice to which the oral composition has been added, and gargling with a mouth wash which includes at least one extract of crude drug selected from the group consisting of glycyrrhizae radix (glycyrrhiza), arecae semen (betel nut), myristicae semen (nutmeg) and leonuri herba (leonurus sibiricus).Type: ApplicationFiled: November 27, 2002Publication date: February 26, 2004Inventor: Shuji Watanabe
-
Publication number: 20030215462Abstract: Methods for increasing the bioavailability of certain orally administered pharmaceutical compounds by the coadministration of inhibitors of UDP-glucuronosyltransferase (UGT) are disclosed. Particular combinations of UGT inhibitors and pharmaceutical compound are described.Type: ApplicationFiled: December 20, 2002Publication date: November 20, 2003Inventors: Vincent J. Wacher, Leslie Z. Benet
-
Publication number: 20030165533Abstract: The invention relates to disclose some Chinese formula for psoriasis. Whether treatment for psoriasis is targeted at both the hyperproliferative and inflammatory aspect of the topical therapy. Specially, the administration dosage is soft gel, cream, tincture and aerosol etc. topical dosages.Type: ApplicationFiled: January 24, 2003Publication date: September 4, 2003Inventors: Hsu-Shan Huang, Rong Fu Chen
-
Publication number: 20030152616Abstract: The invention relates to compositions and methods for making a transdermal drug delivery system capable of achieving substantially zero-order kinetics for delivery of the active agent over a period of time in excess of 24 hours and at least 72 hours, comprising a pharmaceutically acceptable active agent carrier and a rosin ester which provides a crystal inhibiting and drug stabilizing effect on the active agents incorporated therein.Type: ApplicationFiled: January 29, 2003Publication date: August 14, 2003Applicant: NOVEN PHARMACEUTICALS, INC.Inventor: Rod Lawson Hartwig
-
Publication number: 20030152588Abstract: The invention relates to disclose some Chinese formula for psoriasis. Whether treatment for psoriasis is targeted at both the hyperproliferative and inflammatory aspect of the topical therapy. Specially, the administration dosage is soft gel, cream, tincture and aerosol etc. topical dosages.Type: ApplicationFiled: January 14, 2002Publication date: August 14, 2003Inventors: Hsu-Shan Huang, Rong Fu Chen
-
Publication number: 20030147975Abstract: A pharmaceutical composition which reduces or eliminates the drug abuse potential of central nervous system stimulant comprising: (a) a central nervous system stimulant selected from the group consisting of methylphenidate, amphetamine, methamphetamine, and combinations thereof; and (b) a mucous membrane irritant selected from the group consisting of organic and inorganic acid, salt, ketone, nitrite, sulfide, bisulfate, persulfate, glycerophosphate, hypophosphate, borate, titanate, amino acid, peptide, and combinations thereof, wherein the mucous membrane irritant produces irritation when contacted with the skin or mucous membrane.Type: ApplicationFiled: March 10, 2003Publication date: August 7, 2003Inventors: Yatindra Joshi, Russell Somma
-
Patent number: 6582702Abstract: An herbal composition comprised of extracts from the following herbs: Garlic (Allium Sativum), Onion (Allium Cepa), Cat Claw (Macfadyena Unguis-cati), Rat Root (Chicocca Alba), Pear Leaf (Persea Americana), Billyweb Bark (Sweetia Panamensis), Strongback (Desmodium Abscendens), Aloe (Aloe Barbadensis), Life Leaf (Bryophyllum Pinnatum), Sarsaparilla (Smilax Officinalis), Bamboo (Aralia Mubicaulis), Geritout (Pluchea Symphytofolia), Hibiscus (Hibiscus Rosa-sinensis), Balsam (Myroxylon Balsamum). The composition acts as a tonic to improve respiration, aid in the elimination of toxins and improves overall vitality.Type: GrantFiled: July 10, 2001Date of Patent: June 24, 2003Inventor: Alvin Foster Rigby
-
Publication number: 20030100877Abstract: An absorbent garment comprising skin wellness ingredients is disclosed, where the skin wellness ingredients are incorporated into an adhesive used in the assembly of the garment. By incorporating the skin wellness ingredients into the adhesive, the skin wellness ingredients can be precisely placed on those portions of the absorbent garment where at least perceived skin care benefits for the wearer's skin are desired.Type: ApplicationFiled: November 27, 2001Publication date: May 29, 2003Inventor: Carol L. Erdman
-
Publication number: 20030099666Abstract: The invention provides a biological dressing for treatment of a dermatological disease comprised of a gum resin, a topically acceptable volatile solvent, and a pharmacologically active agent. The gum resin is present in a suitable amount that the composition, when the solvent evaporates, will dry to form a solid coating that sticks to the skin or mucosal membrane to which the composition is applied and maintain the pharmacologically active agent over a sustained period of time in contact with sites on the skin or mucosal membranes exhibiting symptoms of the disease. Methods are provided for treating symptoms of dermatological diseases with such a pharmacological composition. Biological dressings including tincture of benzoin and clotrimazole are shown to be efficacious for the long-term amelioration of symptoms of athlete's foot.Type: ApplicationFiled: January 18, 2002Publication date: May 29, 2003Inventor: Alex Battaglia
-
Publication number: 20030091668Abstract: A process and composition for controlling fecal hair excretion and trichobezoar formation in animals such as cats and rabbits is provided and includes feeding the animal a composition comprising from about 10 to about 42 wt % crude protein, from about 4 to about 30 wt % fat, from about 1 to about 25 wt % total dietary fiber, and a supplemental fiber source. The supplemental fiber source is present in amounts which provide from about 1 to about 13 weight percent of supplemental total dietary fiber. The animal is maintained on the diet for a sufficient period of time to control fecal hair excretion and trichobezoar formation.Type: ApplicationFiled: May 6, 2002Publication date: May 15, 2003Applicant: The Iams CompanyInventors: Gary Mitchell Davenport, Gregory D. Sunvold, Gregory A. Reinhart, Michael Griffin Hayek
-
Patent number: 6558712Abstract: A stable, water-soluble delivery system of a purified Shilajit composition obtained by extraction of native Shilajit, containing at least 40% by weight of a carrier which is purified fulvic acid, characterized by having a sponge-like structure punctured by voids of about 200-1000 Å in diameter, and a {overscore (M)}n molecular weight of about 700-2500; and an effective amount of an active pharmaceutical, nutritional or cosmetic ingredient added to said carrier and filling voids therein.Type: GrantFiled: September 21, 2001Date of Patent: May 6, 2003Assignees: Natreon Inc., Indian Herbs Research & Supply Company Ltd.Inventor: Shibnath Ghosal
-
Patent number: 6555125Abstract: Pharmaceutical compositions are provided which comprise effective amounts of antimicrobials, anti-inflammatories, and antihistamines, to provide an ulcer medication which prevents secondary infections and promotes healing while providing immediate relief from pain. The composition may be used to treat a variety of ulcers including but not limited to intraoral aphthous ulcers and non-oral lesions. The compositions of the present invention may also be combined with materials capable of forming seals over ulcers or lesions to further promote the healing process.Type: GrantFiled: October 17, 2001Date of Patent: April 29, 2003Inventor: Phillip Campbell
-
Publication number: 20030077238Abstract: The invention is a cosmetic incorporating the concepts of Traditional Chinese Medicine. Powdered gemstones and pigments selected for their therapeutic effect are blended into a cosmetic powder. A consumer applies a skin gel to the user's skin, lips or hair. The consumer applies the cosmetic powder to the skin gel. Powdered gemstones and pigments may be added to nail coating for application to nails. The consumer realizes the benefits of the gemstones under Traditional Chinese Medicine through proximity of the gemstones to the consumer when used as a cosmetic.Type: ApplicationFiled: September 6, 2002Publication date: April 24, 2003Inventors: Maria Magdalena Catharina Roovers, Rudi Westerkamp, Pierre Blais
-
Publication number: 20030072770Abstract: Compositions of plant carbohydrates for dietary supplements and nutritional support for promotion and maintenance of good health. Defined nutritionally effective amounts of one to eleven essential saccharides, glyconutrients, are used in various inventive compositions as dietary supplements. The dietary composition herein can include phytonutrients, vitamins, minerals, herbal extracts, and other non-toxic nutrients. The glyconutritional dietary supplement herein provides essential saccharides which are the building blocks of glycoproteins. These compositions, when administered orally or topically, have been found to improve the well being of mammals suffering from a variety of disorders.Type: ApplicationFiled: November 14, 2002Publication date: April 17, 2003Applicant: Mannatech, Inc.Inventors: Bill H. McAnalley, H. Reginald McDaniel, D. Eric Moore, Eileen P. Vennum, William C. Fioretti